Chemomab Therapeutics Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
Chemomab Therapeutics Ltd. has filed 352 SEC EDGAR filings since 07 Nov 2011

SEC filing history

Showing 276-300 of 352 matching filings.

Per page
25
Current page
12
3

3 filing

Filing date
31 Dec 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
21 Nov 2019
Reporting date
21 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86953

SC 13G/A

Filing date
18 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
15 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
28 Oct 2019
Reporting date
28 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
23 Sep 2019
Reporting date
23 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
13 Aug 2019
Reporting date
13 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
06 Aug 2019
Reporting date
05 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-232757

FORM S-8

Filing date
22 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
08 Jul 2019
Reporting date
08 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
27 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86953

SC 13G/A

Filing date
26 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
18 Jun 2019
Reporting date
18 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86953

SC 13G

Filing date
11 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
28 May 2019
Reporting date
28 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
22 May 2019
Reporting date
22 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-38807

FORM 20-F

Filing date
25 Mar 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
14 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
12 Mar 2019
Reporting date
12 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

PALISADE MEDICAL EQUITY I, LP

Filing date
25 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86953

SCHEDULE 13D

Filing date
21 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

FORM 6-K

Filing date
14 Feb 2019
Reporting date
14 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-229155

FINAL PROSPECTUS

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .